arrow
M

Marie Warrer Munch

department of intensive care
H指数:12
被引数:1,046

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trial

高血糖和胰岛素使用在COVID-19合并严重低氧血症患者中分配接受12 mg与6 mg地塞米松的情况:COVID STEROID 2随机试验的二次分析

2025-07-150
OAAI
Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19-a post hoc analysis of the randomized, blinded COVID STEROID 2 trial
2023-03-021
OAAI
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

地塞米松12 mg与6 mg在新型冠状病毒肺炎和严重低氧血症患者中的长期结果

2022-03-3117
OAAI
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

地塞米松12 mg与6 mg治疗新型冠状病毒肺炎和严重低氧血症患者: COVID类固醇2试验的预先计划的二次贝叶斯分析

2021-11-1081
OAAI
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia The COVID STEROID 2 Randomized Trial

12毫克vs 6毫克地塞米松对新型冠状病毒肺炎和严重低氧血症成人无生命支持存活天数的影响COVID类固醇2随机试验

2021-11-09184
OA
A new tool to assess Clinical Diversity In Meta-analyses (CDIM) of interventions

一种评估干预措施荟萃分析 (CDIM) 临床多样性的新工具

2021-07-0129
OAAI
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
2021-04-19161
OAAI